BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16172904)

  • 1. Satraplatin activation by haemoglobin, cytochrome C and liver microsomes in vitro.
    Carr JL; Tingle MD; McKeage MJ
    Cancer Chemother Pharmacol; 2006 Apr; 57(4):483-90. PubMed ID: 16172904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid biotransformation of satraplatin by human red blood cells in vitro.
    Carr JL; Tingle MD; McKeage MJ
    Cancer Chemother Pharmacol; 2002 Jul; 50(1):9-15. PubMed ID: 12111106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on cellular accumulation of satraplatin and its major metabolite JM118 and their interactions with glutathione.
    Kostrhunova H; Kasparkova J; Gibson D; Brabec V
    Mol Pharm; 2010 Dec; 7(6):2093-102. PubMed ID: 20936822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel mechanisms of platinum drug resistance identified in cells selected for resistance to JM118 the active metabolite of satraplatin.
    Samimi G; Kishimoto S; Manorek G; Breaux JK; Howell SB
    Cancer Chemother Pharmacol; 2007 Feb; 59(3):301-12. PubMed ID: 16770583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the cellular pharmacology of JM118, the major metabolite of satraplatin, by copper influx and efflux transporters.
    Samimi G; Howell SB
    Cancer Chemother Pharmacol; 2006 Jun; 57(6):781-8. PubMed ID: 16170571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative protein binding, stability and degradation of satraplatin, JM118 and cisplatin in human plasma in vitro.
    Bell DN; Liu JJ; Tingle MD; Rattel B; Meyer TU; McKeage MJ
    Clin Exp Pharmacol Physiol; 2008 Dec; 35(12):1440-6. PubMed ID: 18671714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of nitro reduction in rat liver microsomes by haemin and haemoproteins.
    Jonen HG; Bonow JH; Kugler M; Kahl R; Kahl GF
    Xenobiotica; 1978 May; 8(5):281-8. PubMed ID: 664750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical antitumor activity of the oral platinum analog satraplatin.
    Wosikowski K; Lamphere L; Unteregger G; Jung V; Kaplan F; Xu JP; Rattel B; Caligiuri M
    Cancer Chemother Pharmacol; 2007 Sep; 60(4):589-600. PubMed ID: 17541592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [NADH-dependent electron transfer system of liver microsomes. The oxidation-reduction mechanism of cytochrome b5 (author's transl)].
    Onishi T
    Hokkaido Igaku Zasshi; 1974 Sep; 49(5):397-410. PubMed ID: 4376123
    [No Abstract]   [Full Text] [Related]  

  • 10. Redox-coupled dynamics and folding in cytochrome c.
    Sagle LB; Zimmermann J; Matsuda S; Dawson PE; Romesberg FE
    J Am Chem Soc; 2006 Jun; 128(24):7909-15. PubMed ID: 16771505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel function of glutathione transferase in rat liver mitochondrial membrane: role for cytochrome c release from mitochondria.
    Lee KK; Shimoji M; Hossain QS; Sunakawa H; Aniya Y
    Toxicol Appl Pharmacol; 2008 Oct; 232(1):109-18. PubMed ID: 18634816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status and future prospects for satraplatin, an oral platinum analogue.
    Choy H; Park C; Yao M
    Clin Cancer Res; 2008 Mar; 14(6):1633-8. PubMed ID: 18347164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can Satraplatin be hydrated before the reduction process occurs? The DFT computational study.
    Bradáč O; Zimmermann T; Burda JV
    J Mol Model; 2013 Nov; 19(11):4669-80. PubMed ID: 22643969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of platinum(II)-assisted platinum(IV) substitution for the oxidation of guanosine derivatives by platinum(IV) complexes.
    Choi S; Vastag L; Larrabee YC; Personick ML; Schaberg KB; Fowler BJ; Sandwick RK; Rawji G
    Inorg Chem; 2008 Feb; 47(4):1352-60. PubMed ID: 18220340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cytochrome c containing nitrate reductase plays a role in electron transport for denitrification in Thermus thermophilus without involvement of the bc respiratory complex.
    Cava F; Zafra O; Berenguer J
    Mol Microbiol; 2008 Oct; 70(2):507-18. PubMed ID: 18761683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome P450 oxidation of the thiophene-containing anticancer drug 3-[(quinolin-4-ylmethyl)-amino]-thiophene-2-carboxylic acid (4-trifluoromethoxy-phenyl)-amide to an electrophilic intermediate.
    Medower C; Wen L; Johnson WW
    Chem Res Toxicol; 2008 Aug; 21(8):1570-7. PubMed ID: 18672911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electron transfer patterns of the di-heme protein cytochrome c(4) from Pseudomonas stutzeri.
    Raffalt AC; Schmidt L; Christensen HE; Chi Q; Ulstrup J
    J Inorg Biochem; 2009 May; 103(5):717-22. PubMed ID: 19217165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymatic reduction of labile iron by organelles of the rat liver. Superior role of an NADH-dependent activity in the outer mitochondrial membrane.
    Pamp K; Kerkweg U; Korth HG; Homann F; Rauen U; Sustmann R; de Groot H; Petrat F
    Biochimie; 2008 Oct; 90(10):1591-601. PubMed ID: 18627785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of Platinum(IV) Prodrugs by Cytochrome c and Characterization of the Protein Binding Sites.
    Lasorsa A; Stuchlíková O; Brabec V; Natile G; Arnesano F
    Mol Pharm; 2016 Sep; 13(9):3216-23. PubMed ID: 27505350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study on the redox state dependent gamma(CH) vibrational modes of the c-type heme.
    Dörr S; Wolpert M; Hellwig P
    Biopolymers; 2006 Jul; 82(4):349-52. PubMed ID: 16419062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.